Quantcast

Latest Antidepressant Stories

2014-05-21 23:07:28

Mental health watchdog Citizens Commission on Human Rights says a new report issued by the Centers for Disease Control and Prevention (CDC) on the 10,000 toddlers being prescribed ADHD drugs, is only the tip of the iceberg regarding children being prescribed psychiatric drugs in the U.S. According to IMS health, more than 274,000 0-1 year olds are being prescribed psychiatric drugs and a staggering 370,000 toddlers. Los Angeles, California (PRWEB) May 21, 2014 While the recent New York...

2014-05-12 23:09:29

Wright & Schulte LLC Files Effexor Lawsuit on Behalf of an Ohio Woman Who’s Child Was Born with Birth Defects Allegedly Due to the Antidepressant Drug Effexor Columbus, OH (PRWEB) May 12, 2014 An Effexor lawsuit was filed by Wright & Schulte LLC on behalf of an Ohio woman whose child was born with birth defects allegedly because she took the SSRI antidepressant drug Effexor while she was pregnan t. This Effexor lawsuit was filed in the U.S. District Court, Northern District of...

2014-05-09 08:26:05

-- Expansion to Approximately 600 Sales Specialists Follows Initiation of National Television Advertising Campaign -- SAN DIEGO, May 9, 2014 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) today reported that Eisai plans to add more than 200 new contract sales representatives to its Metabolic Business Unit, increasing the sales force for BELVIQ® by 50% to approximately 600, triple the size from the commercial launch of BELVIQ in June 2013. Eisai expects this expansion of the sales...

2014-05-06 23:10:51

Hundreds of impassioned protesters, including veterans, marched against the American Psychiatric Association which held more than 65 sessions on psychiatric treatment of military personnel, veterans and their families during its annual convention in New York. Citizens Commission on Human Rights launched a petition requesting the U.S. House of Representatives Veterans Affairs Committee to investigate with public hearings the role of psychiatric drugs in veteran suicides, sudden deaths and...

2014-05-06 16:32:06

Companion health economics analysis shows Transcranial Magnetic Stimulation (TMS) is cost-effective among patients who fail to benefit from prior antidepressant medication NEW YORK, May 6, 2014 /PRNewswire/ -- Neuronetics, Inc. announced today a new analysis of data at the annual meeting of the American Psychiatric Association that shows Transcranial Magnetic Stimulation (TMS) administered with the NeuroStar TMS Therapy System resulted in greater symptom improvement than next-choice...

2014-05-06 16:26:53

CARDIFF, Calif., May 6, 2014 /PRNewswire/ -- NI Research has released the May issue of NeuroPerspective, which features a comprehensive review of pharmacotherapies for depression, with a particular focus upon the companies developing RAADs, rapid-acting antidepressants, an approach that springs from the reports of accelerated depression relief via the use of ketamine, and has been further invigorated by the success of Naurex's GlyX-13 in clinical testing. As NeuroPerspective publisher Harry...

2014-05-06 14:42:47

Pilot study reveals a majority of medication-free patients treated with NeuroStar TMS experienced remission after 6 weeks with durable effects through 3 months Neuronetics, Inc. announced today results from a new, dual-arm randomized pilot study that showed a trend toward symptomatic improvements with once-monthly TMS maintenance therapy in medication-free patients treated with NeuroStar TMS Therapy® for Major Depressive Disorder (MDD). Six weeks of acute NeuroStar TMS Therapy induced...

2014-05-06 08:34:13

- Lead NMDA Receptor Modulator GLYX-13 Shows Robust and Sustained Antidepressant Effects with Repeat Dosing and Is Well-Tolerated in Subjects with Difficult-to-Treat Depression - EVANSTON, Ill., May 6, 2014 /PRNewswire/ -- Naurex Inc., a privately held biopharmaceutical company leveraging its unique platform to develop novel drugs for diseases of the central nervous system (CNS), today announced that its two lead antidepressant programs achieved major milestones. Top-line results...

2014-05-05 16:26:47

Pilot Study Reveals a Majority of Medication-Free Patients Treated with NeuroStar TMS Experienced Remission After Six Weeks with Durable Effects Through Three Months NEW YORK, May 5, 2014 /PRNewswire/ -- Neuronetics, Inc. announced today results from a new, dual-arm randomized pilot study that showed a trend toward symptomatic improvements with once-monthly TMS maintenance therapy in medication-free patients treated with NeuroStar TMS Therapy(®) for Major Depressive Disorder (MDD)....

2014-05-04 08:21:24

GeneSight Psychotropic Expands to Cover 38 FDA-Approved Antidepressant and Antipsychotic Medications MASON, Ohio, May 4, 2014 /PRNewswire/ -- Assurex Health today announced an enhancement of its GeneSight® Psychotropic test, providing clinicians with the most comprehensive genetic-based tool available to help them make individualized antidepressant and antipsychotic medication decisions for patients with depression, anxiety, post-traumatic stress disorder (PTSD), bipolar disorder,...


Word of the Day
endocarp
  • The hard inner (usually woody) layer of the pericarp of some fruits (as peaches or plums or cherries or olives) that contains the seed.
This word comes from the Greek 'endon,' in, within, plus the Greek 'kardia,' heart.
Related